Adverum Biotechnologies Inc - Company Profile
Powered by
All the data and insights you need on Adverum Biotechnologies Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Adverum Biotechnologies Inc Strategy Report
- Understand Adverum Biotechnologies Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Adverum Biotechnologies Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
SI3472317T1 | Grant | COMPOSITIONS AND METHODS FOR REDUCING OCULAR NEOVASCULARIZATION | A61K2039/505; A61K2039/5256; A61K2039/54; A61K31/46; A61K31/496; A61K38/00; A61K39/3955; A61K48/005; A61K48/0075; A61K9/0019; A61K9/0048; A61K9/10; A61P27/02; C07K14/005; C07K16/22; C07K2317/24; C07K2317/55; C07K2317/76; C07K2319/00; C12N15/86; C12N2750/14122; C12N2750/14143; C12N7/00 | August 31, 2022 |
EP4049683A1 | Application | EVASION VON NEUTRALISIERENDEN ANTIKÖRPERN DURCH EIN REKOMBINANTES ADENO-ASSOZIIERTES VIRUS | A61K48/005; A61K48/0075; A61K9/0048; A61P27/02; C07K16/08; C07K2317/76; C12N15/86; C12N2750/14143 | August 31, 2022 |
US11427931B2 | Grant | Mutant viral capsid libraries and related systems and methods | C07K14/005; C12N15/1037; C12N15/1082; C12N15/1086; C12N15/86; C12N2750/14111; C12N2750/14122; C12N2750/14143; C40B40/02; C40B40/08; C40B50/06 | August 30, 2022 |
US20220265740A1 | Application | TREATMENT OF AMD USING AAV2 VARIANT WITH AFLIBERCEPT | A61K35/761; A61K9/0019; A61P27/02; C12N15/86 | August 25, 2022 |
US20220259568A1 | Application | COMPOSITIONS AND METHODS FOR ENHANCED GENE EXPRESSION IN CONE CELLS | A61K35/761; A61K48/00; C12N15/86; C12N7/00 | August 18, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer